🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The overall goal of this study is to inform the design and establish feasib...
Status
Not Yet Recruiting
Location
Botswana Harvard Health Partnership
Start Date
2026-06-01
Trial ID
NCT07576842
Cervical cancer disproportionately affects women in low- and middle-income ...
Status
Not Yet Recruiting
Location
Research for Development (RD) Rwanda
Start Date
2026-05-31
Trial ID
NCT07390916
Treatments Being Tested
RATIONALE: Vaccines made from human papillomavirus may make the body build ...
Status
Completed
Location
Innsbruck Universitaetsklinik
Start Date
1996-11
Trial ID
NCT00002916
This study will be looking at what dose of the TA-CIN vaccine is safe and e...
Status
Completed
Location
Women & Infants Center, University of Alabama at Birmingham
Start Date
2019-04-04
Trial ID
NCT02405221
Treatments Being Tested
Cervical cancer disproportionately affects women in low- and middle-income ...
Status
Not Yet Recruiting
Location
Coptic Hope Center
Start Date
2026-03
Trial ID
NCT07468695
Treatments Being Tested
RATIONALE: Vaccines made from DNA or a gene-modified virus may help the bod...
Status
Completed
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Start Date
2008-11
Trial ID
NCT00788164
Treatments Being Tested
Cervical cancer disproportionately affects women in low- and middle-income ...
Status
Not Yet Recruiting
Location
Centre for the AIDS Programme of Research in South Africa
Start Date
2026-06
Trial ID
NCT07645378
Treatments Being Tested
This phase II trial tests how well pB1-11 and human papillomavirus tumor an...
Status
Recruiting
Location
University of Alabama Birmingham
Start Date
2023-07-26
Trial ID
NCT05799144
A Feasibility Trial of PVX7 vaccine in advanced cervical cancer patients wh...
Status
Recruiting
Location
The University of Alabama at Birmingham
Start Date
2025-07-23
Trial ID
NCT06315257
Treatments Being Tested
The primary to assess the safety and tolerability of TA-CIN and anti-PD-1 t...
Status
Withdrawn
Location
Women & Infants Center, University of Alabama at Birmingham
Start Date
2021-08
Trial ID
NCT05132803
Treatments Being Tested